Next generation sequencing in breast cancer

preview_player
Показать описание
Maria Fernanda Mosele, MD, Gustave Roussy, Villejuif, France, talks on the advantages of next generation sequencing (NGS) for accessing new treatments. This interview took place at the European Society for Medical Oncology (ESMO) Breast Cancer 2022 congress in Berlin, Germany.
Рекомендации по теме